Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

radiotherapy

  • You have access
    Adverse Events of Concurrent Radiotherapy and ALK Inhibitors for Brain Metastases of ALK-Rearranged Lung Adenocarcinoma
    TAKAAKI NAKASHIMA, TAKESHI NONOSHITA, HIDENARI HIRATA, KOUJI INOUE, AKIRA NAGASHIMA, TADAMASA YOSHITAKE, KAORI ASAI and YOSHIYUKI SHIOYAMA
    In Vivo January 2020, 34 (1) 247-253; DOI: https://doi.org/10.21873/invivo.11767
  • You have access
    E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy
    PINELOPI GKOGKOU, EVANGELIA PEPONI, DIMITRIOS NTASKAGIANNIS, SAMUEL MURRAY, ASIMO DEMOU, IOANNIS SAINIS, ELLI IOAKEIM, EVANGELOS BRIASOULIS and PERICLES TSEKERIS
    In Vivo January 2020, 34 (1) 453-459; DOI: https://doi.org/10.21873/invivo.11795
  • You have access
    Simultaneous Integrated Boost in Once-weekly Hypofractionated Radiotherapy for Breast Cancer in the Elderly: Preliminary Evidence
    ELISABETTA BONZANO, LILIANA BELGIOIA, GIORGIA POLIZZI, GUIDO SIFFREDI, PIERO FREGATTI, DANIELE FRIEDMAN, STEFANIA GARELLI, MARCO GUSINU, ELENA MARIA LUISA VACCARA, MARINA GUENZI and RENZO CORVÒ
    In Vivo November 2019, 33 (6) 1985-1992; DOI: https://doi.org/10.21873/invivo.11694
  • You have access
    Efficacy of Palliative Bladder Radiotherapy for Hematuria in Advanced Bladder Cancer Using Contemporary Radiotherapy Techniques
    JEREMY TEY, YU YANG SOON, TIMOTHY CHEO, KIAT HUAT OOI, FRANCIS HO, BALAMURUGAN VELLAYAPPAN, DAVID CHIA and BEE CHOO TAI
    In Vivo November 2019, 33 (6) 2161-2167; DOI: https://doi.org/10.21873/invivo.11718
  • You have access
    Dosimetric Comparison of Sequential Versus Simultaneous-integrated Boost in Early-stage Breast Cancer Patients Treated With Breast-conserving Surgery
    CEM ONAL, ESMA EFE, OZAN C. GULER and BERNA A. YILDIRIM
    In Vivo November 2019, 33 (6) 2181-2189; DOI: https://doi.org/10.21873/invivo.11720
  • You have access
    Hypofractionated Accelerated Chemo-radiotherapy (Chemo-HypoAR) With Cisplatin and Liposomal Doxorubicin for the Treatment of Patients With Uterine Sarcomas
    SPYROS DOMOXOUDIS, IOANNIS M. KOUKOURAKIS, AXIOTIS G. GIAKZIDIS and MICHAEL I. KOUKOURAKIS
    In Vivo September 2019, 33 (5) 1621-1624; DOI: https://doi.org/10.21873/invivo.11646
  • You have access
    Phase Angle as an Objective and Predictive Factor of Radiotherapy-induced Changes in Body Composition of Male Patients With Head and Neck Cancer
    TERESA MAŁECKA-MASSALSKA, TOMASZ POWRÓZEK, MONIKA PRENDECKA, RADOSŁAW MLAK, GRZEGORZ SOBIESZEK, WOJCIECH BRZOZOWSKI and ANNA BRZOZOWSKA
    In Vivo September 2019, 33 (5) 1645-1651; DOI: https://doi.org/10.21873/invivo.11650
  • You have access
    Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation
    KAZUMA KOBAYASHI, NAOYA MURAKAMI, KANA TAKAHASHI, KOJI INABA, RYUJI HAMAMOTO and JUN ITAMI
    In Vivo September 2019, 33 (5) 1659-1665; DOI: https://doi.org/10.21873/invivo.11652
  • You have access
    Hypofractionated Intensity-modulated Radiotherapy for Intermediate- and High-risk Prostate Cancer: A Retrospective Study
    NOBUTERU KUBO, HIDEMASA KAWAMURA, TAKAHIRO OIKE, HIRO SATO, MOTOTARO IWANAGA, TATSUJI MIZUKAMI, AKIKO ADACHI, HIROSHI MATSUI, KAZUTO ITO, KAZUHIRO SUZUKI and TAKASHI NAKANO
    In Vivo July 2019, 33 (4) 1235-1241; DOI: https://doi.org/10.21873/invivo.11595
  • You have access
    Successful Treatment of Anal Canal Cancer Metastasis to the Cranial Bones: A Case Report and Literature Review
    ILARIA BENEVENTO, FRANCESCA DE FELICE, NADIA BULZONETTI, ROSSELLA CAIAZZO, RAFFAELE CASSESE, DANIELA MUSIO and VINCENZO TOMBOLINI
    In Vivo July 2019, 33 (4) 1347-1353; DOI: https://doi.org/10.21873/invivo.11610

Pages

  • Previous
  • Next
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
In Vivo

© 2026 In Vivo

Powered by HighWire